Comparison of prostate cancer detection rates of various prostate biopsy methods for patients with prostate-specific antigen levels of <10.0 ng/mL in real-world practice

Lignende værker

• Is targeted biopsy really needed when performing systematic prostate biopsy to raise the detection rate for prostate cancer in patients with prostate-specific antigen ≤10 ng/mL?
  af: Park, Jee Soo, et al.
  Udgivet: (2019)
• Validation of the Effectiveness of Neutrophil-to-lymphocyte Ratio (NLR) as a Predictive Factor in Patients Undergoing Prostate Biopsy With Prostate Specific Antigen (PSA) Between 4.0 and 10.0 ng/ml
  af: MASUDA, HIROSHI, et al.
  Udgivet: (2021)
• Prostate-Specific Antigen Kinetics Following 5α-Reductase Inhibitor Treatment May Be a Useful Indicator for Repeat Prostate Biopsy
  af: Heo, Ji Eun, et al.
  Udgivet: (2018)
• The association of family history of prostate cancer with the diagnosis of clinically significant prostate cancer in Korean population
  af: Jee Soo Park, et al.
  Udgivet: (2019-11-01)
• The association of family history of prostate cancer with the diagnosis of clinically significant prostate cancer in Korean population
  af: Park, Jee Soo, et al.
  Udgivet: (2019)